IL15 and neoplasm: They also evaluated the efficacy of 4G-CAR-T cells in vivo in a B16 melanoma tumor model and found that 4G-CAR-T cells showed greater persistence and greater efficacy against tumor cells when compared to CAR-T cells without IL-15 secretion (59).